Lucienne Ide

This represents a new phase of data access, where hundreds of glucose reads per day per sensor provide greater insights into each patient’s disease management.

Within two years, it is expected that more than 70 million U.S. patients will benefit from remote patient monitoring. Yet some misunderstandings persist.